Advertisement

Topics

FDA issues final guidance in effort to protect clinical trial participants

12:23 EDT 17 May 2018 | Outsourcing-Pharma

The FDA has published a final guidance today in its efforts to improve protection for participants in clinical trials and reduce regulatory burden.

Original Article: FDA issues final guidance in effort to protect clinical trial participants

NEXT ARTICLE

More From BioPortfolio on "FDA issues final guidance in effort to protect clinical trial participants"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...